Coherus Oncology · 12 hours ago
Sr. Manager, Investor Relations
Redwood City, CA
Full-time
Onsite
Mid, Senior Level
$140K/yr - $175K/yr
1+ years expCoherus Biosciences is a biotechnology company seeking a Sr. Manager of Investor Relations to support their investor relations programs. This role involves delivering corporate messages to the investment community, managing investor events, and coordinating corporate communications.
BiotechnologyHealth CareMedicalOncologyTherapeutics
Responsibilities
Coordinate, track and capture summarized insights from investor meetings
Monitor news sources for competitive information and investment personal changes and identify key IR opportunities
Provide support for all investor/analyst events (includes all logistical aspects of such events, and the preparation of presentation and briefing materials)
Assist in responding to shareholder/analyst inquires in a timely manner and schedule follow up meetings
Create briefing templates and reports for senior management and board of directors
Develop and maintain IR materials and messaging documents for use by company spokespersons
Assist with the quarterly earnings process (includes press release, Q&A document, supporting materials, and conference call logistics)
Manage corporate communications materials (press releases / social media content) and coordinate closely with the legal department on relevant public communications
Organize and calendar scientific symposia, medical conferences and investor events
Manage the department budget
Qualification
Required
BA/BS in finance, business or communications
1-2 years of progressive investor relations experience in a publicly traded biotech/pharmaceutical company
Strong understanding and knowledge in business analytics and financial research
Understanding of financial statements and valuation models
Able to adapt quickly to a high-growth, fast paced environment
Strong analytical, organizational and interpersonal skills
Outstanding cross-functional teamwork/skills
Strong attention to detail
Preferred
MBA
Corporate communications experience
Company
Coherus Oncology
Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.27BKey Investors
Pharmakon AdvisorsNorthern Star PartnersShanghai Junshi Biosciences
2023-05-15Post Ipo Equity· $50M
2022-01-07Post Ipo Debt· $100M
2022-01-01Post Ipo Debt· $400M
Leadership Team
Dennis Lanfear
Founder, President, and Chief Executive Officer
Richard Hameister
Chief Technical Officer
Recent News
2026-01-06
2026-01-05
Company data provided by crunchbase